drugset / Trial / NCT01514981
AMG 761 in Adults With Asthma
RandomizedSingle-groupTriple-blindBasic science
Summary
The purpose of this study is to determine that no significant safety issues will be identified following a single dose of AMG 761 in asthma subjects that would preclude further development of AMG 761.
Timeline
- Start
- 2011-12
- Primary completion
- 2014-01
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mogamulizumab | Monoclonal antibody | — | — |